AnovoRX
Exclusive Rare Disease Specialty Pharmacy
- Employees
- 201–500
- Business Model
- B2B
- Website
- anovorx.com
- Last Round
- Growth EquityJan 2022
- Rounds
- 1
About
AnovoRx is an independent specialty pharmacy focused exclusively on rare and ultra-rare disease therapies with integrated HUB and 3PL services.
Summary
AnovoRX is a Healthcare company based in United States. Its most recent funding was a Growth Equity round in Jan 2022. Investors include TPG (Growth/Rise).
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe